Rilpivirine Z-Isomer is an isomeric impurity that may form in Rilpivirine formulations under specific conditions.

Monitoring this isomeric impurity is essential to ensure the safety and efficacy of Rilpivirine formulations, as mandated by regulatory bodies.

It forms under specific synthesis or storage conditions that lead to isomeric impurity development in Rilpivirine.

Careful synthesis control and appropriate storage conditions help minimize its formation.

Detection is achieved using advanced techniques like GC-MS, LC-MS, and HPLC-MS.

Chemicea provides COA, H-NMR, MASS, HPLC, and TGA reports, with additional documentation available upon request.

Yes, Chemicea’s documentation meets the standards required by USFDA, EMA, ANVISA, PMDA, and other regulatory agencies.

Stable for shipping at room temperature; specific storage conditions are provided in the COA.

Yes, Chemicea offers both standard and customized pack sizes based on client needs.

Chemicea supplies this isomeric impurity as a reference standard, supporting regulatory compliance and quality control efforts.